Journal

Oncopept: Russia’s First Personalised Peptide Cancer Vaccine Enters Clinical Use

Oncopept has moved a patient-specific tumour-to-peptide workflow into clinical use in Russia. Explore how the platform works, the research supporting it and the cohort evidence that can define its precision-oncology potential.